Stock listing

Hyundai Bioscience Co. Ltd.

Selected listing: 048410 · KRX · KRW · KR

Hyundai Bioscience Co. Ltd. (KRX:048410), Health Technology. Latest release May 24, 2021: CNPharm’s Game Changer COVID-19 Drug Introduced in World Class…

048410:KRXKRWKRUpdated October 3, 2026
Hyundai Bioscience Co. Ltd. logo
Ticker
KRX:048410
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
KRX
Currency
KRW

About Hyundai Bioscience Co. Ltd.

Hyundai Bioscience Co. Ltd. is a public company listed under the ticker 048410 in the Korean market. Hyundai Bioscience focuses on biotechnology and life sciences, contributing to advancements in health and wellness.

Latest news from Hyundai Bioscience Co. Ltd.

CNPharm’s Game Changer COVID-19 Drug Introduced in World Class Academic Journal

May 23, 2021

Hyundai Bioscience: Niclosamide-based CP-COV03, an Oral Antiviral Drug May Be a Problem Solver for COVID-19

May 14, 2021

All Hyundai Bioscience Co. Ltd. news →

Research Hyundai Bioscience Co. Ltd.

Hyundai Bioscience Co. Ltd. company profile

View the public company page for Hyundai Bioscience Co. Ltd. on 6ix.

Hyundai Bioscience Co. Ltd. news

Read company news and market updates connected to Hyundai Bioscience Co. Ltd..

Hyundai Bioscience Co. Ltd. investor events

Find investor webinars, events, and replay context for Hyundai Bioscience Co. Ltd..